Your browser doesn't support javascript.
loading
[Lung disease in adult common variable immunodeficiency]. / Atteintes respiratoires au cours du déficit immunitaire commun variable de l'adulte.
Hadjadj, J; Malphettes, M; Fieschi, C; Oksenhendler, E; Tazi, A; Bergeron, A.
Afiliación
  • Hadjadj J; U1153 CREBS, Biostatistics and Clinical Epidemiology Research Team, service de pneumologie, hôpital Saint-Louis, AP-HP, université Paris Diderot, Sorbonne Paris Cité, 75010 Paris, France.
  • Malphettes M; Département d'immuno-hématologie, hôpital Saint-Louis, AP-HP, 75010 Paris, France.
  • Fieschi C; Département d'immuno-hématologie, hôpital Saint-Louis, AP-HP, 75010 Paris, France.
  • Oksenhendler E; Département d'immuno-hématologie, hôpital Saint-Louis, AP-HP, 75010 Paris, France.
  • Tazi A; U1153 CREBS, Biostatistics and Clinical Epidemiology Research Team, service de pneumologie, hôpital Saint-Louis, AP-HP, université Paris Diderot, Sorbonne Paris Cité, 75010 Paris, France.
  • Bergeron A; U1153 CREBS, Biostatistics and Clinical Epidemiology Research Team, service de pneumologie, hôpital Saint-Louis, AP-HP, université Paris Diderot, Sorbonne Paris Cité, 75010 Paris, France. Electronic address: anne.bergeron-lafaurie@sls.aphp.fr.
Rev Mal Respir ; 32(10): 991-1001, 2015 Dec.
Article en Fr | MEDLINE | ID: mdl-26071128
ABSTRACT

INTRODUCTION:

Common variable immunodeficiency (CVID) is characterized by a defect in antibody production and may be complicated by infectious or non-infectious respiratory disease.

BACKGROUND:

In addition to recurrent infectious complications, mainly due to encapsulated bacteria, CVID may be complicated by diffuse infiltrative, non-infectious lung disease. The latter may be related to granulomatosis, lymphoid interstitial pneumonia, follicular bronchiolitis, follicular nodular hyperplasia, organizing pneumonia or lymphoma. Different lymphoid histological lesions can co-exist and form a new entity called GLILD (granulomatous lymphocytic interstitial lung disease), which is associated with a poor prognosis. Replacement of immunoglobulins significantly decreases the frequency and severity of infections but has no impact on the non-infectious complications. OUTLOOK Studies are needed to determine the modalities of follow-up and better understand the long-term progress of GLILD. These studies should improve the management of GLILD in the context of immunosuppressive treatments, which increase the risk of infection in CVID.

CONCLUSION:

The identification of GLILD, which reflects a variable histological spectrum, rather than a well-defined entity, necessitates revising the approach to diffuse infiltrative lung diseases in CVID.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunodeficiencia Variable Común / Enfermedades Pulmonares Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Idioma: Fr Revista: Rev Mal Respir Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunodeficiencia Variable Común / Enfermedades Pulmonares Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Idioma: Fr Revista: Rev Mal Respir Año: 2015 Tipo del documento: Article